VEXIM, a France-based company developing medical devices for the minimally invasive treatment of vertebral fractures, received regulatory approval to commercialize its SpineJack implant and Masterflow system in Australia.
Here are four highlights:
1. Australia's Therapeutic Goods Administration approved the two devices.
2. VEXIM plans to commercially launch these two products in Australia by the end of 2016.
3. SpineJack is intended to restore a fractured vertebra to its initial shape and restore the spinal column's anatomy.
4. The Masterflow system offers a solution for mixing and injecting orthopedic cement to improve the accuracy of injection.